Skip to main content

Table 2 The distribution of HPV-16 positive patients based on gender, age groups, and cancer diagnosis

From: Molecular detection of human papillomavirus-16 among Sudanese patients diagnosed with squamous cell carcinoma and salivary gland carcinoma

 

HPV-16

Total

P value

Negative

Positive

Gender

 Female

58 (82.9%)

12 (17.1%)

70 (46.7%)

0.564

 Male

66 (82.5%)

14 (17.5%)

80 (53.3%)

Age group

 1–30 years

2 (33.3%)

4 (66.7%)

6 (4.0%)

0.002

 31–60 years

104 (86.7%)

16 (13.3%)

120 (80.0%)

 61–90 years

18 (75.0%)

6 (25.0%)

24 (16.0%)

Cancer diagnosis

 Esophageal SCC

26 (65.0%)

14 (35.0%)

40 (26.7%)

0.001

 Nasopharyngeal carcinoma

30 (100%)

0 (0.0%)

30 (20.0%)

 Tongue

14 (77.8%)

4 (22.2%)

18 (12.0%)

 Conjunctiva SCC

18 (100%)

0 (0.0%)

18 (12.0%)

 Mucoepidermoid carcinoma

6 (100%)

0 (0.0%)

6 (4.0%)

 Adenoid cystic carcinoma

4 (66.7%)

2 (33.3%)

6 (4.0%)

 Myoepithelial carcinoma

6 (100%)

0 (0.0%)

6 (4.0%)

 Lips SCC

8 (100%)

0 (0.0%)

8 (5.3%)

 Larynx

6 (50.0%)

6 (50.0%)

12 (8.0%)

 Oropharyngeal carcinoma

6 (4.0%)

0 (0.0%)

6 (4.0%)

 Total

124 (82.7%)

26 (17.3%)

150 (100%)